Company Profile
Updated: 05-NOV-09International Laser Expressions Inc.
Private Company, Headquarters Location
245 Asylum St., Norwich, CT 06360, United States
(860)889-7300, (860)887-1033 fax, http://www.minimelts.com
Primary SIC: Candy & Other Confectionery Products, Primary NAICS: Confectionery Manufacturing from Purchased Chocolate
Description: Manufacturing: Candy & Other Confectionery Products
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Rubicon Technology, Inc. Reports Third Quarter 2009 Results and Outlines Two Year Expansion Plan.
Business Wire; 11/3/2009; 1465 words; ...Rubicon Technology, Inc. (NASDAQ:RBCN...801-6888 (international). Callers should...Rubicon Technology, Inc. Rubicon Technology, Inc. is an advanced...RFICs), blue laser diodes, optoelectronics...or similar expressions, or those relating...
Ultratech Receives Follow-On Order for TSV Applications.
PR Newswire; 11/3/2009; 1329 words; ...Ultratech, Inc. , a leading supplier...lithography and laser-processing systems...founder of TechSearch International, "The level of...and similar expressions, are forward...development cycles for laser-processing and...competitors or suppliers; international sales; timing of...
Other News To Note.
BIOWORLD Today; 11/3/2009; 3240 words; ...Sangamo Biosciences Inc. involving targeted...Ciphergen Biosystems Inc., said a publication in the International Journal of Cancer...surface enhanced laser desorption/ionization...Cortex Biochem Inc., of Raleigh...study into the expression of 37 genes that...
QUARK EXPANDS PATENT PROTECTION FOR COMPOUNDS TARGETING RTP801 GENE.
AsiaPulse News; 10/26/2009; 1322 words; ...Pharmaceuticals Expands International Patent Protection...Pharmaceuticals, Inc., a development...Phase application of International (PCT) Patent Application...designed to inhibit the expression of RTP801 and is...4523655 versus laser therapy in 160 patients...Pharmaceuticals, Inc. ...
Quark Pharmaceuticals Expands International Patent Protection for Compounds Targeting the RTP801 Gene.
PR Newswire; 10/26/2009; 1172 words; ...Pharmaceuticals, Inc., a development...application of International (PCT) Patent...to inhibit the expression of RTP801 and...4523655 versus laser therapy in 160...Pharmaceuticals, Inc. Quark Pharmaceuticals, Inc. is a development...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning